Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AFRM vs GSK✓SelectedUSD · GSKAFRM vs GSK performance historyLatest closeAs of-3.69%11/16
Stock and ETF performance explorer

AFRM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-8.0%
GSK return
+9.7%
Excess return
-17.7%
Maximum drawdown
-48.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.7%-0.1%-3.6%-3.7%
7D-7.8%-1.3%-6.5%-7.8%
30D-15.3%+2.7%-18.0%-15.2%
3M-20.0%+2.7%-22.7%-19.4%
6M-4.7%+3.3%-8.1%-4.3%
YTD-15.7%+6.5%-22.2%-15.0%
All-8.0%+9.7%-17.7%-7.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling